Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas

J Gauthier; L Holmberg; D Wu; W Bensinger; A K Gopal; O Press; D Maloney; D J Green; B G Till; D Byelykh; A Shustov

doi:10.1038/bmt.2016.227

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas

Bone Marrow Transplant. 2016 Dec;51(12):1617-1619. doi: 10.1038/bmt.2016.227. Epub 2016 Oct 24.

Authors

J Gauthier^{1

2

3}, L Holmberg^{1

4}, D Wu⁵, W Bensinger^{1

4}, A K Gopal^{1

4}, O Press^{1

4}, D Maloney^{1

4}, D J Green^{1

4}, B G Till^{1

4}, D Byelykh⁶, A Shustov^{1

6}

Affiliations

¹ Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA.
² CHRU Lille, Pôle spécialités médicales et gérontologie, service des Maladies du Sang, secteur allogreffe de cellules souches hématopoïétiques, Lille, France.
³ Université de Lille, UFR Médecine, Lille, France.
⁴ Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA.
⁵ Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA, USA.
⁶ Division of Haematology, University of Washington School of Medicine, Seattle, WA, USA.

PMID: 27775693
DOI: 10.1038/bmt.2016.227

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Flow Cytometry*
Humans
Immunophenotyping
Lymphoma, T-Cell, Peripheral / therapy*
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm, Residual / diagnosis*
Retrospective Studies
Stem Cell Transplantation*
Time Factors
Transplantation, Autologous
Treatment Outcome